The Preconditioning Effect of Sevoflurane on Coronary Artery Bypass Surgery Patients
Journal of Cellular & Molecular Anesthesia,
Vol. 3 No. 2 (2018),
2 Shahrivar 2018
,
Page 66-73
https://doi.org/10.22037/jcma.v3i2.21785
Abstract
Background: One of the most important issues in the field of surgery is ischemic preconditioning (IPC) of the myocardium during the coronary artery bypass grafting (CABG). The current study attempted to reevaluate the issue to find a potential approach to diminish morbidity, inotrope administration, ischemia and possibly intensive care unit stay after CABG in adult patients.Materials and Methods: Through randomized single-blind clinical trial, all elective coronary bypass surgeries in 40 to 80 years-old patients enrolled the study. Atrioventricular (AV) block (mobitz2); complete heart block; left bundle branch block (LBBB); acute heart failure (ejection fraction (EF) <30%); re-exploration due to surgical complications and MI cases in the last 7 days were excluded. In all patients, induction (sufentanil, cis-atracurium and etomidate) and maintenance phase (sufentanil, midazolam, cis-atracurium) of anesthesia were done following the same protocol. After cross-clamp of aorta in intervention group, the patients received oxygen (2Lit/min) and sevoflurane (4%) during coronary bypass surgery. After rewarming of the patients, sevoflurane was discontinued. Main outcome measures were troponin 4, 8, 24, 48 hours after surgery with charting the electrocardiogram (ECG) changes, need for inotrope agents and hemodynamic indices during and after CABG in ICU.Results: 58 CABG candidates enrolled the current study: 29 in intervention group and 29 in control group. There were no statistical differences between the groups concerning hemodynamic issues, Central Venous Pressure (CVP), hematocrit (HCT), ECG changes, demands for inotrope, or ICU stay between the groups.Conclusion: No significant relationship between application of 4% sevoflurane and IPC was found in adult CABG patients. However, the effect of Sevoflurane on IPC might be dose-related.Keywords: Ischemic preconditioning (IPC); Sevoflurane; Coronary Artery Bypass Surgery (CABG)
- Ischemic preconditioning (IPC)
- Sevoflurane
- Coronary Artery Bypass Surgery (CABG)
How to Cite
References
Shvedova M, Anfinogenova Y, Popov SV, Atochin DN. Connexins and Nitric Oxide Inside and Outside Mitochondria: Significance for Cardiac Protection and Adaptation. Front Physiol. 2018;9:479.
Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74(5):1124-36.
Miller RD. Miller's anesthesia. 8th ed, 2014, Saunders, Philadelphia.ISBN: 9780702052835.
El Dib R, Guimarães Pereira JE, Agarwal A, Gomaa H, Ayala AP, Botan AG, Braz LG, de Oliveira LD, Lopes LC, Mathew PJ. Inhalation versus intravenous anaesthesia for adults undergoing on-pump or off-pump coronary artery bypass grafting: A systematic review and meta-analysis of randomized controlled trials. J Clin Anesth. 2017;40:127-138.
Annecke T, Kubitz JC, Kahr S, et al. Effects of sevoflurane and propofol on ischaemia–reperfusion,injury after thoracic-aortic occlusion in pigs. Br J Anaesth. 2007;98(5):581-90.
Fräßdorf J, Borowski A, Ebel D, et al. Impact of preconditioning protocol on anesthetic-induced cardioprotection in patients having coronary artery bypass surgery. J ThoracCardiovasc Surg. 2009;137(6):1436-42.
Bein B, Renner J, Caliebe D, et al. The effects of interrupted or continuous administration of sevoflurane on preconditioning before cardio-pulmonary bypass in coronary artery surgery: comparison with continuous propofol. Anaesthesia. 2008;63(10):1046-55
Kortekaas KA, van der Baan A, Aarts LP, et al. Cardiospecific sevoflurane treatment quenches inflammation but does not attenuate myocardial cell damage markers: a proof-of-concept study in patients undergoing mitral valve repair. British Journal of Anaesthesia. 2014;112(6):1005-14.
Kawamura T, Kadosaki M, Nara N, et al. Effects of sevoflurane on cytokine balance in patients undergoing coronary artery bypass graft surgery. J CardiothoracVascAnesth. 2006;20(4):503-8
Bouwman R A, Musters R J P, van Beek-Harmsen B J, et al. Sevoflurane-induced cardioprotection depends on PKC-α activation via production of reactive oxygen species. British Journal of Anaesthesia. 2007;99(5):639-45.
Lorsomradee S, Cromheecke S, Lorsomradee S, De Hert SG. Effects of sevoflurane on biomechanical markers of hepatic and renal dysfunction after coronary artery surgery. J CardiothoracVascAnesth. 2006; 20(5):684-90
Lemoine S, Zhu L, Gérard JL, Hanouz JL. Sevoflurane-induced cardioprotection in coronary artery bypass graft surgery: Randomised trial with clinical and ex-vivo endpoints. Anaesth Crit Care Pain Med. 2018;37(3):217-23.
Wang J, Cheng J, Zhang C, Li X. Cardioprotection Effects of Sevoflurane by Regulating the Pathway of Neuroactive Ligand-Receptor Interaction in Patients Undergoing Coronary Artery Bypass Graft Surgery.Computational and Mathematical Methods in Medicine. 2017:7.
Zhang J, Wang S. Effects of sevoflurane on cardiopulmonary function in patients undergoing coronary artery bypass.J BiolRegulHomeost Agents. 2016;30(4):1079-83
Lu Y, Wang L, Liu N, Dong T, Li R. Sevoflurane preconditioning in on-pump coronary artery bypass grafting: a meta-analysis of randomized controlled trials.J Anesth. 2016;30(6):977-86.
Likhvantsev VV, Landoni G, Levikov DI, Grebenchikov OA, Skripkin YV, Cherpakov RA. Sevoflurane Versus Total Intravenous Anesthesia for Isolated Coronary Artery Bypass Surgery With Cardiopulmonary Bypass: A Randomized Trial.J CardiothoracVascAnesth. 2016;30(5):1221-7.
Sirvinskas E, Kinderyte A, Trumbeckaite S. Effects of sevoflurane vs. propofol on mitochondrial functional activity after ischemia-reperfusion injury and the influence on clinical parameters in patients undergoing CABG surgery with cardiopulmonary bypass.Perfusion. 2015;30(7):590-5.
- Abstract Viewed: 207 times
- PDF Downloaded: 139 times